This week we will be sharing results from a study of VRX1116, a simian analog for an investigational, lentiviral-based vaccine for HIV VRX1273, at the AIDS Vaccine 2010 conference in Atlanta, GA. This conference is focused on bringing together HIV opinion leaders. We are honored and exited to be sharing our research, which we feel has reached a milestone. AIDS Vaccine 2010 is being held September 28 – October 1, 2010 at the Omni Hotel in Atlanta, Georgia. The VRX1116 data will be presented as “Highly immunogenic lentiviral vaccine provides control of viral load, preservation of the CD4 compartment, and survival advantage post-SIV challenge” at 6:30pm Eastern Standard Time.